Written Question·Department of Health and Social Care·UIN 28088

Givinostat

Tabled: 3 February 2025
Answered: 10 February 2025

Question

Jo Platt

Labour (Co-op)Leigh and Atherton

To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to ensure that all eligible NHS Trusts participate in the early access programme for givinostat.

Answer

Karin Smyth
ITF Pharma UK, the United Kingdom marketing authorisation holder for givinostat, is providing access to givinostat through a type of compassionate use scheme called an Early Access Programme (EAP). Under the EAP, givinostat is free to both patients taking...

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 28088) →